MedPass Blog ICON Acquires MedPass International

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has acquired MedPass International, the leading European medical device CRO, regulatory and reimbursement consultancy, that specialises in medical device development and market access. This acquisition, concluded in late January, further [...]The post ICON Acquires MedPass International appeared first on MedPass international - Medical Device CRO based in Europe.